Day: September 29, 2023

Brétéché inaugurates the first station in its low-carbon hydrogen distribution network at Maché in Vendée (France) This Dual Pressure 350 and 700 bar station, with a capacity of up to 1 ton per day, will supply hydrogen to light, commercial and then heavy vehicles for professionals and private customers With this new reference, McPhy supports Brétéché in its decarbonization initiatives and strengthens its position in the hydrogen mobility segmentGrenoble, September 29, 2023 – 7:45 am CEST – McPhy Energy, specialized in low-carbon hydrogen production and distribution equipment (electrolyzers and refueling stations), today announces the inauguration and commissioning of a Dual Pressure hydrogen station for Brétéché, petroleum products distributor and subsidiary of France’s leading independent petroleum network, AVIA...

Bilbao, Spain, September 29.- Virtualware (EPA: MLVIR), the European leader in the virtual reality industry, has participated at the NATO Air Operation exercise focused on chemical, biological, radiological, and nuclear (CBRN) Def interoperability to present the VR training project for the Spanish Health Forces. The Koksijde air base, in West Flanders, in Belgium has hosted this large-scale NATO (CBRN) defense exercise called Toxic Trip 2023, from Saturday September 23 to Friday September 29, that brought together 600 military personnel. Specialist from 18 NATO countries (including Belgium, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Lithuania, the Netherlands, Romania, Spain, Turkey, the United Kingdom and the United States) practiced and tested passive defense and CBRN techniques and procedures. The aim was to enhance...

Ad hoc announcement pursuant to Art. 53 LR Samuel Künzli will step down as Feintool Chief Financial Officer and member of the executive board at the end of March 2024 to pursue a new challenge outside the company. Over the past three years, Samuel Künzli has played a significant role in the transformation of the Feintool Group, with a particular focus on Green Energy, leading to important achievements and milestones. The board of directors and executive management team at the Feintool Group extend their gratitude to Samuel Künzli for the successful collaboration during his tenure and wish him all the best in his future endeavors. The succession process will commence immediately. Alexander von Witzleben, Chairman of the Feintool Board of Directors, stated: “We regret that Samuel Künzli is leaving our company. As Chief Financial Officer,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) “High Arctic” or the “Corporation” provides an update on the contemplated reorganization of the Corporation, including the associated tax efficient $38.2 million return of capital, the Papua New Guinea focused business spin-out to shareholders, refocus of the Canadian business and an update on its Papua New Guinea (“PNG”) operations. The Corporation has received feedback from shareholders and is working with its advisors on the reorganization plan to incorporate key elements of the shareholder feedback. The High Arctic board has reserved...

CONSHOHOCKEN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced the pricing of its underwritten public offering of 1,248,098 shares of its common stock at a public offering price of $151.69 per share, and, to certain investors, pre-funded warrants to purchase 2,048,098 shares of common stock at a price of $151.6899 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each such pre-funded warrant. The gross proceeds to Madrigal from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $500...

ROCHESTER, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, today announced it has entered into securities purchase agreements with healthcare focused institutional investors along-side significant participation from an entity affiliated with the Chairman of the Company’s Board of Directors, and existing investors of the Company for the purchase and sale of 9,600,000 shares of the Company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 9,600,000 shares of common stock at a purchase price per share (and accompanying warrant) of $1.00 in its “reasonable best efforts”...